Open AccessJournal Article
Paraprosthetic leak: a complication of cardiac valve replacement.
Reads0
Chats0
TLDR
Clinical evidence of prosthetic valve infection was found in 79% of MVR and 67% of AVR and a heavily calcified aortic annulus, found in 47% of patients, may also have contributed to PPL after AVR.Abstract:
Paraprosthetic leak (PPL) is a rare but potentially serious complication of cardiac valve replacement. Between 1974 and 1988, 1175 prosthetic valves were implanted in 1026 patients by one cardiac surgeon at St. Thomas' Hospital, London. Of these 539 (52.5%) were aortic (AVR), 334 (32.6%) mitral (MVR), 7 (0.7%) tricuspid, and 144 (14%) AV and MV double valve replacements (DVR). There were only 2 triple valve replacements. The prosthetic valves implanted were the Starr-Edwards (7%), Bjork Shiley (11.8%), Lillehei-Kaster (23%), Carpentier-Edwards bioprosthesis (35.2%), Duromedics bileaflet (16.4%) and a variety of other mechanical and bioprosthetic valves (6.6%). Over the 15 year period there were a total of 82 (7%) valve failures of which PPL was diagnosed in 29 (2.5%) valves in 24 patients. Presenting features included cardiac decompensation in 72%, bacterial endocarditis in 12% and haemolytic anaemia in 12%. One patient (4%) had no symptoms. Nineteen patients underwent re-operation. Median time to re-operation was 15 months (range 1-65 months) with a re-operative mortality of 22%. Clinical evidence of prosthetic valve infection was found in 79% of MVR and 67% of AVR. A heavily calcified aortic annulus, found in 47% of patients, may also have contributed to PPL after AVR.read more
Citations
More filters
Journal ArticleDOI
Prosthetic heart valves
TL;DR: More than 80 models of prosthetic heart valves have been developed and used since the 1950s and more than 60,000 valve replacements are performed annually in the United States.
Journal ArticleDOI
Prevalence and clinical significance of incidental paraprosthetic valvar regurgitation: a prospective study using transoesophageal echocardiography.
TL;DR: Small paraprosthetic leaks are common, are related to surgical factors, are not associated with increased subclinical haemolysis, and are benign during the first year after heart valve replacement.
Journal ArticleDOI
Clinical outcomes in patients undergoing percutaneous closure of periprosthetic paravalvular leaks.
Carlos E. Ruiz,Vladimir Jelnin,Itzhak Kronzon,Yuriy Dudiy,Raquel del Valle-Fernández,Bryce Einhorn,Paul T.L. Chiam,Claudia Martinez,Rocio Eiros,Gary S. Roubin,Howard A. Cohen +10 more
TL;DR: Percutaneous closure of symptomatic paravalvular leaks, facilitated by integrated imaging modalities has a high rate of acute and long-term success and appears to be effective in managing symptoms of heart failure and hemolytic anemia.
Journal ArticleDOI
Paravalvular leakage after mitral valve replacement: improved long-term survival with aggressive surgery?
Michele Genoni,Daniel Franzen,Paul R. Vogt,Burkhardt Seifert,Rolf Jenni,Andreas Künzli,Urs Niederhäuser,Marko Turina +7 more
TL;DR: Following mitral valve replacement, a more aggressive surgical treatment is recommended for patients with paraprosthetic leaks and should be offered to less symptomatic patients, as well as those not requiring blood transfusion.
Journal ArticleDOI
Acetyl-coenzyme A synthetase (AMP forming)
TL;DR: Structural work provides snapshots of the dramatic conformational changes Acs undergoes during catalysis and future work on the regulation of acs gene expression will expand the understanding of metabolic integration, while structure/function studies will reveal more details of the function of this splendid molecular machine.